Allianz Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,400
| Closed | -$316K | – | 1642 |
|
|
2024
Q1 | $316K | Hold |
15,400
| – | – | ﹤0.01% | 1519 |
|
|
2023
Q4 | $330K | Buy |
15,400
+700
| +5% | +$15K | ﹤0.01% | 1494 |
|
|
2023
Q3 | $303K | Hold |
14,700
| – | – | ﹤0.01% | 1552 |
|
|
2023
Q2 | $434K | Buy |
14,700
+3,400
| +30% | +$100K | ﹤0.01% | 1337 |
|
|
2023
Q1 | $260K | Hold |
11,300
| – | – | ﹤0.01% | 1529 |
|
|
2022
Q4 | $314K | Hold |
11,300
| – | – | ﹤0.01% | 1411 |
|
|
2022
Q3 | $347K | Sell |
11,300
-3,520
| -24% | -$108K | ﹤0.01% | 1363 |
|
|
2022
Q2 | $436K | Sell |
14,820
-3,000
| -17% | -$88.3K | ﹤0.01% | 1686 |
|
|
2022
Q1 | $574K | Sell |
17,820
-18,325
| -51% | -$590K | ﹤0.01% | 1707 |
|
|
2021
Q4 | $1.62M | Buy |
36,145
+17,410
| +93% | +$778K | ﹤0.01% | 1464 |
|
|
2021
Q3 | $945K | Sell |
18,735
-4,720
| -20% | -$238K | ﹤0.01% | 1581 |
|
|
2021
Q2 | $1.84M | Hold |
23,455
| – | – | ﹤0.01% | 1317 |
|
|
2021
Q1 | $1.34M | Sell |
23,455
-8,805
| -27% | -$503K | ﹤0.01% | 1380 |
|
|
2020
Q4 | $2.7M | Buy |
+32,260
| New | +$2.7M | ﹤0.01% | 1213 |
|
|
2020
Q1 | – | Sell |
-33,154
| Closed | -$577K | – | 2039 |
|
|
2019
Q4 | $577K | Sell |
33,154
-28,062
| -46% | -$488K | ﹤0.01% | 1885 |
|
|
2019
Q3 | $952K | Sell |
61,216
-45
| -0.1% | -$700 | ﹤0.01% | 1703 |
|
|
2019
Q2 | $1.27M | Sell |
61,261
-38,561
| -39% | -$801K | ﹤0.01% | 1688 |
|
|
2019
Q1 | $2.32M | Buy |
99,822
+8,618
| +9% | +$200K | ﹤0.01% | 1521 |
|
|
2018
Q4 | $1.86M | Sell |
91,204
-132,076
| -59% | -$2.7M | ﹤0.01% | 1493 |
|
|
2018
Q3 | $4.85M | Sell |
223,280
-13,510
| -6% | -$294K | ﹤0.01% | 1273 |
|
|
2018
Q2 | $3.61M | Buy |
236,790
+500
| +0.2% | +$7.63K | ﹤0.01% | 1326 |
|
|
2018
Q1 | $4.65M | Buy |
236,290
+36,745
| +18% | +$724K | ﹤0.01% | 1234 |
|
|
2017
Q4 | $3.12M | Buy |
+199,545
| New | +$3.12M | ﹤0.01% | 1378 |
|